Research Overview: Clomiver 50mg Vermodje
Clomiver 50mg is a selective estrogen receptor modulator (SERM) developed by Vermodje for laboratory research examining endocrine system regulation and hormonal pathway mechanisms. This pharmaceutical-grade compound enables researchers to investigate estrogen receptor interactions and their downstream effects in controlled laboratory environments. Scientists at Stroid UK Shop utilise this compound for advanced studies into selective receptor modulation and post-cycle recovery mechanisms. The formulation provides consistent results for researchers examining hormonal equilibrium restoration following anabolic compound research protocols.
Laboratory Research Applications
Research scientists examine Clomiver 50mg for its potential in studying estrogen receptor antagonism and agonism in different tissue types. Laboratory investigations focus on understanding how selective estrogen receptor modulators interact with hypothalamic-pituitary-gonadal axis function. Researchers in the post cycle therapy category analyse this compound’s mechanisms in hormonal recovery studies. Additionally, scientists investigate its applications alongside other research compounds from our SARMs collection and peptide research range to understand synergistic effects in comprehensive endocrine research protocols.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Clomiphene Citrate |
| Concentration | 50mg per tablet |
| Manufacturer | Vermodje |
| CAS Number | 50-41-9 |
| Molecular Formula | C32H36ClNO8 |
| Molecular Weight | 598.08 g/mol |
| Storage Conditions | Cool, dry place below 25°C |
| Research Classification | Selective Estrogen Receptor Modulator |
Research Compliance Information
Clomiver 50mg Vermodje is manufactured exclusively for in-vitro research purposes and laboratory investigations. This compound is not intended for human consumption, therapeutic use, or any applications outside controlled research environments. Researchers must ensure proper handling protocols and maintain appropriate laboratory safety standards when conducting studies with this selective estrogen receptor modulator. All research activities should comply with relevant institutional guidelines and regulatory requirements for pharmaceutical research compounds.
